| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 27.48M | 39.91M | 41.66M | 35.92M | 26.72M |
| Gross Profit | 10.72M | 23.84M | 41.66M | 35.92M | 62.41M |
| EBITDA | -28.59M | 5.21M | -120.73M | 7.79M | 55.39M |
| Net Income | -32.66M | 3.03M | -81.80M | -18.44M | 44.44M |
Balance Sheet | |||||
| Total Assets | 235.72M | 661.20M | 693.89M | 817.78M | 728.39M |
| Cash, Cash Equivalents and Short-Term Investments | 47.89M | 25.01M | 18.06M | 20.26M | 23.28M |
| Total Debt | 82.68M | 96.31M | 280.88M | 288.17M | 198.85M |
| Total Liabilities | 97.29M | 287.09M | 308.96M | 327.81M | 240.88M |
| Stockholders Equity | 138.43M | 374.11M | 384.93M | 489.98M | 487.50M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 16.43M | 19.25M | 23.81M | 11.45M |
| Operating Cash Flow | 6.13M | 16.43M | 19.25M | 23.81M | 11.45M |
| Investing Cash Flow | 359.93M | 33.26M | 17.60M | -133.52M | -193.56M |
| Financing Cash Flow | -343.65M | -42.73M | -39.05M | 106.70M | 180.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £4.44B | 7.70 | 7.16% | 6.67% | 43.70% | 40.28% | |
73 Outperform | £4.07B | 10.57 | 5.78% | 5.30% | 36.45% | -26.38% | |
72 Outperform | £419.35M | 3.34 | 11.57% | 7.17% | 1.60% | 211.81% | |
71 Outperform | £9.43B | 17.68 | 3.51% | 4.25% | 7.56% | -8.46% | |
71 Outperform | £164.07M | 9.16 | 7.33% | 7.43% | -10.95% | -30.09% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
45 Neutral | £94.80M | -3.85 | -13.29% | 65.05% | -29.93% | -1363.64% |